Trial Profile
Clinical Trials Insight: 700022362
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 11 Apr 2007
Price :
$35
*
At a glance
- Drugs Interferon alpha (Primary) ; Interferon alpha-2b (Primary) ; Peginterferon alfa-2a (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Nautilus Biotech
- 11 Apr 2007 New trial record.